In this study, we identified IL-7 as a prognostic biomarker for PAD prognosis and used this circulating myokine in addition to clinical characteristics to develop a model that accurately predicted 2-year MALEs in patients with PAD. The gene discussed is IL7; the disease is peripheral arterial disease.